AlphAIalphai — Financial news for AI agents
stocktitan.netAUG 191 min read$VMD

Viemed Healthcare (NASDAQ: VMD) grants new RSUs and phantom units to director

Viemed Healthcare (VMD) director Sabrina Heltz exercised 15,029 RSUs and 3,757 Phantom Share Units, converting them into common shares. She also received new grants of 12,174 RSUs and 3,043 Phantom Share Units, set to vest in 2027. The Phantom Share Units were settled at $8.94 per share.

Original reporting
stocktitan.net
Published Aug 19, 2026, 8:31 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 20, 2026, 10:55 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefFinancial news
Primary signal
$VMD
Neutral
high confidence
Mentioned
$VMD
Relevance
4/10
alphai data visualization · based on stocktitan.net
Decision brief

The 30-second read

$VMDNeutralLow
01

Why it matters

The filing provides transparency on insider compensation but does not introduce new operational or financial information.

02

Market read

Limited relevance; primarily a routine insider compensation disclosure.

03

What to watch

Potential future dilution from the new RSU grant and phantom units.

Relevance 4/10Novelty 3/10Timing: post‑filing Aug 19 2026

Background

Viemed Healthcare filed a Form 4 reporting recent vesting, cash settlement of phantom shares, and new equity awards to a director.

Company-level read

Ticker impact

$VMDNeutralHigh confidence
Context

Form 4 filing shows director Sabrina Heltz vested 15,029 RSUs and sold 3,757 phantom shares for cash at $8.94 per share on Aug 19, 2026.

Expected impact

Minimal short‑term impact; price may stay flat.

Evidence & confidence

The transaction size (~$34k) is trivial relative to market cap; insider activity is routine and already disclosed.

Market effects

Sector

None; the filing pertains only to Viemed Healthcare.

Regional

None; no broader regional effect.

Global

None; limited to a single micro‑cap.

Counterpoint

What could challenge this read

If the director is signaling confidence, the new RSU grant could be viewed as a bullish sign despite the small cash sale.

Key entities

  • company
    Viemed Healthcare, Inc.

    NASDAQ‑listed provider of healthcare services.

  • person
    Sabrina Heltz

    Director of Viemed Healthcare.

Read at source← All news

Related articles

AUG 20
Med

Viemed Healthcare Announces New Share Repurchase Program of Up to 5% of Shares Outstanding – Minichart

Viemed Healthcare reported Q2 2026 revenue of $78.1M (up 24% Y-o-Y) and Adjusted EBITDA of $13.7M. The company announced a new share repurchase program for up to 5% of outstanding shares, following a strong first half with 680,802 shares repurchased. Full-year 2026 guidance is $314M-$320M in revenue and $64M-$68M in Adjusted EBITDA. The company has a strong balance sheet with $10.7M in cash and no net debt as of June 30, 2026.

minichart.com.sg2 min
AUG 11
$VMDMedAI 8/10

Viemed (VMD) Q2 2026 Earnings Call Transcript

Viemed Healthcare (VMD) reported Q2 2026 revenue of $78.1M, up 24% year over year, with ventilator patient counts reaching 12,635. Adjusted EBITDA was $13.7M (17.6% margin) and net income was $2.8M. Full-year 2026 revenue guidance was raised to $314M-$320M and adjusted EBITDA to $64M-$68M.

fool.com6 min
AUG 6
$VMDMedAI 8/10

Viemed Healthcare Q2 Earnings Call Highlights

Viemed Healthcare (NASDAQ:VMD) reported Q2 updates on home respiratory and sleep therapies. Management cited improved ventilator patient growth and said PAP setups rose, with sleep patients up about 5% sequentially and 44% YoY. Equipment sales nearly doubled to $19M. Gross profit was $45M (57.7% margin). Full-year net revenue guidance raised to $314M-$320M and adjusted EBITDA to $64M-$68M.

yahoo.com6 min
AUG 3
$VMDHigh

VIEMED HEALTHCARE, INC. (VMD): Results of Operations and Financial Condition

VIEMED HEALTHCARE, INC. (VMD) filed an SEC Form 8-K — Results of Operations and Financial Condition. VIEMED HEALTHCARE ANNOUNCES SECOND QUARTER 2026 FINANCIAL RESULTS Lafayette, Louisiana (August 3, 2026) Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, ann

SEC EDGAR 8-K6 min